Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (1243)	12/14/1998 1:51:00 PM
From: Anthony Wong	Respond to of 1722

Eli Lilly & Co. Reiterated 'Strong Buy' at SG Cowen Bloomberg News December 14, 1998, 10:30 a.m. ET Princeton, New Jersey, Dec. 14 (Bloomberg Data) -- Eli Lilly & Co. (LLY US) was reiterated ''strong buy'' by analyst Stephen Scala at SG Cowen. -- Andrew Bekoff in Princeton, New Jersey, (609)279-3652

To: Anthony Wong who wrote (1243)	12/14/1998 1:53:00 PM
From: Anthony Wong	Respond to of 1722

Lilly (Eli) & Co. Reiterated 'Buy' at Gerard Klauer Bloomberg News December 14, 1998, 10:33 a.m. ET Princeton, New Jersey, Dec. 14 (Bloomberg Data) -- Lilly (Eli) & Co. (LLY US) was reiterated ''buy'' by analyst Cynthia A. Beach at Gerard Klauer Mattison & Co. The 12-month target price is $105.00 per share. -- Donna McDonald in Princeton, New Jersey, (609)279-3731

To: Anthony Wong who wrote (1243)	12/14/1998 1:56:00 PM
From: Anthony Wong	Read Replies (2) \| Respond to of 1722

Schering-Plough Corp. Cut to 'Attractive' at Vector Securities Bloomberg News December 14, 1998, 1:11 p.m. ET Princeton, New Jersey, Dec. 14 (Bloomberg Data) -- Schering-Plough Corp. (SGP US) was downgraded to ''attractive'' from ''buy'' by analyst Patricia L. Bank at Vector Securities International. The 12-month target price is $62.00 per share. -- Donna McDonald in Princeton, New Jersey, (609)279-3731

To: Anthony Wong who wrote (1243)	12/14/1998 1:59:00 PM
From: Anthony Wong	Read Replies (1) \| Respond to of 1722

Immunex Corp. Reiterated 'Buy' at Salomon Smith Barney Bloomberg News December 14, 1998, 11:37 a.m. ET Princeton, New Jersey, Dec. 14 (Bloomberg Data) -- Immunex Corp. (IMNX US) was reiterated ''buy'' by analyst Meirav Chovav at Salomon Smith Barney. The 12-month target price is $120.00 per share. -- Andrew Bekoff in Princeton, New Jersey, (609)279-3652